Table 1.
Eleven alternative splicing events selected for validation .
| Gene | Full name | Coordinates | Type of splicing event | Canonical | |
|---|---|---|---|---|---|
| GIT2 | GIT ArfGAP 2 | chr12 | 110,418,984–110,421,415 | Insertion | No |
| CTNNB1 | Catenin beta 1 | chr3 | 41,280,845–41,281,310 | Deletion | Yes |
| MKNK2 | MAP kinase interacting serine/threonine kinase 2 | chr19 | 2,037,828–2,040,133 | Deletion | Yes |
| MRPL33 | Mitochondrial ribosomal protein L33 | chr2 | 27,975,814–28,002,300 | Alternative start | No |
| SIPA1L3 | Signal-induced proliferation associated 1-like 3 | chr19 | 38,423,332–38,519,729 | Alternative start | No |
| SNHG6 | Small nucleolar RNA host gene 6 | chr8 | 67,834,960–67,838,433 | Alternative start | No |
| SYCP2 | Synaptonemal complex protein 2 | chr20 | 58,496,505–58,497,445 | Alternative start | Yes |
| TPRG1 | Tumour protein P63 regulated 1 | chr3 | 189,027,966–189,028,175 | Alternative start | No |
| ZHX2 | Zinc fingers and homeoboxes 2 | chr8 | 123,875,561–123,875,716 | Alternative start | No |
| ZNF331 | Zinc finger protein 331 | chr19 | 54,058,142–54,059,099 | Alternative start | Yes |
| ELOVL1a | ELOVL fatty acid elongase 1 | chr1 | 43,831,294–43,831,939 | Alternative start | No |
aASE under-expressed in tumours
Genomic coordinates, as aligned to GRCh37/hg19, are shown of the junction correlating with the alternative splicing event identified.